相似文献
1
Increased risk of cancer in patients with systemic lupus erythematosus.
Ann Rheum Dis. 1992 Apr;51(4):437-9. doi: 10.1136/ard.51.4.437.
2
Increased incidence of cancer in systemic lupus erythematosus: a Finnish cohort study with more than 25 years of follow-up.
Scand J Rheumatol. 2018 Nov;47(6):461-464. doi: 10.1080/03009742.2017.1384054. Epub 2018 Jan 10.
3
Non-Hodgkin's lymphoma and other cancers among a cohort of patients with systemic lupus erythematosus.
Arthritis Rheum. 1997 Apr;40(4):761-8. doi: 10.1002/art.1780400424.
4
Is there an association of malignancy with systemic lupus erythematosus? An analysis of 276 patients under long-term review.
Rheumatology (Oxford). 2000 Oct;39(10):1147-52. doi: 10.1093/rheumatology/39.10.1147.
5
Bidirectional relationship between systemic lupus erythematosus and non-Hodgkin's lymphoma: a nationwide population-based study.
Rheumatology (Oxford). 2019 Jul 1;58(7):1245-1249. doi: 10.1093/rheumatology/kez011.
6
Increased cancer risk in patients with cutaneous lupus erythematosus and systemic lupus erythematosus compared with the general population: A Danish nationwide cohort study.
Lupus. 2021 Apr;30(5):752-761. doi: 10.1177/0961203321990106. Epub 2021 Jan 26.
7
A closer look at non-Hodgkin's lymphoma cases in a national Swedish systemic lupus erythematosus cohort: a nested case-control study.
Ann Rheum Dis. 2007 Dec;66(12):1627-32. doi: 10.1136/ard.2006.067108. Epub 2007 May 21.
8
Incidence of cancer among female patients with systemic lupus erythematosus in Korea.
Clin Rheumatol. 2010 Apr;29(4):381-8. doi: 10.1007/s10067-009-1332-7. Epub 2009 Dec 30.
9
An international cohort study of cancer in systemic lupus erythematosus.
Arthritis Rheum. 2005 May;52(5):1481-90. doi: 10.1002/art.21029.
10
Malignancy in systemic lupus erythematosus.
Arthritis Rheum. 1996 Jun;39(6):1050-4. doi: 10.1002/art.1780390625.
引用本文的文献
1
Malignancy in neuromuscular patients on chronic IVIG.
Front Neurol. 2025 Jun 24;16:1571160. doi: 10.3389/fneur.2025.1571160. eCollection 2025.
2
Inextricable association of connective tissue disease with B‑cell lymphoma (Review).
Mol Clin Oncol. 2025 Apr 1;22(6):48. doi: 10.3892/mco.2025.2843. eCollection 2025 Jun.
3
The Association Between Myasthenia Gravis and Higher Extrathymic Cancer Risk.
Brain Behav. 2025 Jan;15(1):e70143. doi: 10.1002/brb3.70143.
4
Elevated levels of IL-12/IL-23p40 in Nova Scotia Duck Tolling Retrievers with autoimmune disease and lymphoma.
Sci Rep. 2024 May 21;14(1):11624. doi: 10.1038/s41598-024-62265-y.
5
Hematological malignancies in systemic lupus erythematosus: clinical characteristics, risk factors, and prognosis-a case-control study.
Arthritis Res Ther. 2022 Jan 3;24(1):5. doi: 10.1186/s13075-021-02692-8.
6
Contribution of viral infection to risk for cancer in systemic lupus erythematosus and multiple sclerosis.
PLoS One. 2021 Jan 22;16(1):e0243150. doi: 10.1371/journal.pone.0243150. eCollection 2021.
7
Primary breast diffuse large B-cell lymphoma in a patient with systemic lupus erythematosus: A case report and review of the literature.
Medicine (Baltimore). 2020 Aug 14;99(33):e21736. doi: 10.1097/MD.0000000000021736.
8
The relationship between cancer and medication exposure in patients with systemic lupus erythematosus: a nested case-control study.
Arthritis Res Ther. 2020 Jun 26;22(1):159. doi: 10.1186/s13075-020-02228-6.
9
Primary central nervous system lymphoma in neuropsychiatric systemic lupus erythematosus: case-based review.
Rheumatol Int. 2021 May;41(5):1009-1017. doi: 10.1007/s00296-020-04569-6. Epub 2020 Apr 6.
10
The risks of cancer development in systemic lupus erythematosus (SLE) patients: a systematic review and meta-analysis.
Arthritis Res Ther. 2018 Dec 6;20(1):270. doi: 10.1186/s13075-018-1760-3.
本文引用的文献
1
THE DEVELOPMENT OF MALIGNANT LYMPHOMA IN THE COURSE OF SJOEGREN'S SYNDROME.
Am J Med. 1964 Apr;36:529-40. doi: 10.1016/0002-9343(64)90101-9.
2
Cancer in connective tissue disease.
Arthritis Rheum. 1982 Sep;25(9):1130-3. doi: 10.1002/art.1780250916.
3
Systemic lupus erythematosus with paraproteinemia.
Arthritis Rheum. 1984 Jun;27(6):638-44. doi: 10.1002/art.1780270606.
4
Autoimmune and immunoproliferative diseases of NZB/Bl mice and hybrids.
Int Rev Exp Pathol. 1966;5:217-52.
5
Malignancy in a series of 70 patients with systemic lupus erythematosus.
Arthritis Rheum. 1974 Jul-Aug;17(4):383-90. doi: 10.1002/art.1780170407.
6
Normal, autoimmune, and malignant CD5+ B cells: the Ly-1 B lineage?
Annu Rev Immunol. 1988;6:197-218. doi: 10.1146/annurev.iy.06.040188.001213.
7
Cancer in autoimmune diseases.
Semin Arthritis Rheum. 1988 Nov;18(2):77-87. doi: 10.1016/0049-0172(88)90001-7.
8
The relationship between autoimmune states and B cell proliferations.
J Rheumatol. 1989 Aug;16(8):1023-4.
9
Increased proto-oncogene expression in peripheral blood lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases.
Arthritis Rheum. 1986 Jun;29(6):755-60. doi: 10.1002/art.1780290608.
10
Rheumatic diseases and cancer.
Clin Exp Rheumatol. 1991 Mar-Apr;9(2):109-12.
Zotero 插件